Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Banco Santander SA (SAN) Price & Performance

ACADIA Pharmaceuticals Inc.Trade
Banco Santander SATrade

Price performance (Past 24H)

Key statistics

ACADIA Pharmaceuticals Inc. vs Banco Santander SA — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.07B), while Banco Santander SA trades at $14.86 (market cap $211.63B). The key difference: Banco Santander SA is far larger — about 41.7× ACADIA Pharmaceuticals Inc.'s market cap, and Banco Santander SA pays a 1.89% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.

ACADSAN
Market Cap
$5.07B$211.63B
Sector
HealthFinancials
52-Week High
$29.41$14.71
52-Week Low
$20.06$9.37
Enterprise Value
$4.19B
Dividend Yield
1.89%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Read more on ACAD

About Banco Santander SA

Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.

Read more on SAN